{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:37:28Z","timestamp":1792658248970,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ejpb.2014.08.002","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T16:54:51Z","timestamp":1407948891000},"page":"945-953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer"],"prefix":"10.1016","volume":"88","author":[{"given":"Peter","family":"Boyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-9786","authenticated-orcid":false,"given":"Ian","family":"Major","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McConville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2014.08.002_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2012.03.047","article-title":"Susceptibility to cervical cancer: an overview","volume":"126","author":"de Freitas","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejpb.2014.08.002_b0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00130404-200309000-00004","article-title":"The epidemiology of cervical cancer","volume":"9","author":"Franco","year":"2009","journal-title":"Cancer J."},{"key":"10.1016\/j.ejpb.2014.08.002_b0015","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cncr.25065","article-title":"Cervical cancer prevention: new tools and old barriers","volume":"116","author":"Scarinci","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejpb.2014.08.002_b0020","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffma","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejpb.2014.08.002_b0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajog.2011.01.033","article-title":"Treating cervical cancer: breast and cervical cancer prevention and treatment act patients","volume":"204","author":"Chien","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejpb.2014.08.002_b0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2011.11.031","article-title":"Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers","volume":"159","author":"Wolinsky","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2014.08.002_b0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13346-011-0024-4","article-title":"Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections","volume":"1","author":"Friend","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2014.08.002_b0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13346-011-0031-5","article-title":"Ethylene vinyl acetate intravaginal rings for the simultaneous delivery of the antiretroviral UC781 and contraceptive levonorgestrel","volume":"1","author":"Loxley","year":"2011","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2014.08.002_b0045","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jac\/dki326","article-title":"Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings","volume":"56","author":"Malcolm","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2014.08.002_b0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s13346-012-0101-3","article-title":"Development of a UC781 releasing poly ethylene vinyl acetate vaginal ring","volume":"2","author":"McConville","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2014.08.002_b0055","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jps.23528","article-title":"Preformulation and development of a once-daily sustained-release tenofovir vaginal tablet containing a single excipient","volume":"102","author":"McConville","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2014.08.002_b0060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jac\/dks422","article-title":"Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques","volume":"68","author":"Malcolm","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2014.08.002_b0065","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2014.08.002_b0070","series-title":"Enhancement in Drug Delivery","first-page":"395","article-title":"Vagina and uterus as drug-absorbing organs","author":"Malcolm","year":"2006"},{"key":"10.1016\/j.ejpb.2014.08.002_b0075","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v17.i5.30","article-title":"Drug delivery by the intravaginal route","volume":"17","author":"Woolfson","year":"2000","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ejpb.2014.08.002_b0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0168-3659(95)00018-4","article-title":"A bioadhesive patch cervical drug delivery system for the administration of 5-fluorouracil to cervical tissue","volume":"35","author":"Woolfson","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2014.08.002_b0085","first-page":"192","article-title":"Phase II trial of betaall-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap","volume":"145","author":"Graham","year":"1986","journal-title":"West. J. Med."},{"key":"10.1016\/j.ejpb.2014.08.002_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1471-0528.1985.tb01096.x","article-title":"Topical 5-fluorouracil in the treatment of vaginal intraepithelial neoplasia","volume":"92","author":"Kirwan","year":"1985","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.ejpb.2014.08.002_b0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2006.08.014","article-title":"Cervical cancer treatment with a locally insertable controlled release delivery system","volume":"115","author":"Keskar","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2014.08.002_b0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2012.07.097","article-title":"Localized delivery of chemotherapy to the cervix for radiosensitization","volume":"127","author":"Hodge","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejpb.2014.08.002_b0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0168-3659(99)00148-0","article-title":"Design of an intravaginal ring for the controlled delivery of 17beta-estradiol as its 3-acetate ester","volume":"61","author":"Woolfson","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2014.08.002_b0110","series-title":"Modified Release Drug Delivery Technology","first-page":"499","article-title":"Vaginal rings for controlled release drug delivery","author":"Malcolm","year":"2008"},{"key":"10.1016\/j.ejpb.2014.08.002_b0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13625180701577122","article-title":"Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing\u00ae: results of clinical experience in Germany","volume":"13","author":"Brucker","year":"2008","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"10.1016\/j.ejpb.2014.08.002_b0120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0168-3659(03)00277-3","article-title":"Design of a silicone reservoir intravaginal ring for the delivery of oxybutynin","volume":"91","author":"Woolfson","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2014.08.002_b0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30mg of ethinyl estradiol and 3mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ejpb.2014.08.002_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/psb.526","article-title":"NuvaRing: new combined hormonal contraceptive device","volume":"20","author":"Chaplin","year":"1999","journal-title":"Prescriber"},{"key":"10.1016\/j.ejpb.2014.08.002_b0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9378(96)70378-2","article-title":"A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging","volume":"174","author":"Henriksson","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejpb.2014.08.002_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcp.2006.08.016","article-title":"Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients","volume":"73","author":"Wickstr\u00f6m","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2014.08.002_b0145","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2011.126","article-title":"Disulfiram modulated ROS\u2013MAPK and NFkB pathways and targeted breast cancer cells with cancer stem cell-like properties","volume":"104","author":"Yip","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejpb.2014.08.002_b0150","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/bjc.2012.442","article-title":"Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells","volume":"107","author":"Liu","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejpb.2014.08.002_b0155","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1158\/0008-5472.CAN-06-2126","article-title":"Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2014.08.002_b0160","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1158\/1078-0432.CCR-09-1035","article-title":"High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth","volume":"15","author":"Iljin","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejpb.2014.08.002_b0165","doi-asserted-by":"crossref","first-page":"e51470","DOI":"10.1371\/journal.pone.0051470","article-title":"Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells","volume":"7","author":"Ketola","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2014.08.002_b0170","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1349-7006.1999.tb00722.x","article-title":"Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways","volume":"90","author":"Minagawa","year":"1999","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.ejpb.2014.08.002_b0175","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1158\/1535-7163.1049.3.9","article-title":"Disulfiram inhibits activating transcription factor\/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease","volume":"3","author":"Brar","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejpb.2014.08.002_b0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01877380","article-title":"Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study","volume":"6","author":"Dufour","year":"1993","journal-title":"Biotherapy"},{"key":"10.1016\/j.ejpb.2014.08.002_b0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000421-199004000-00007","article-title":"A randomized phase II study of cisplatin alone versus cisplatin plus disulfiram","volume":"13","author":"Verma","year":"1990","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2014.08.002_b0190","first-page":"197","article-title":"Disulfiram induces apoptosis in human melanoma cells: a redox-related process","volume":"1","author":"Cen","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejpb.2014.08.002_b0195","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1021\/jm049568z","article-title":"Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells","volume":"47","author":"Cen","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejpb.2014.08.002_b0200","first-page":"217","article-title":"Copper","volume":"37","author":"Barceloux","year":"1999","journal-title":"J. Toxicol."},{"key":"10.1016\/j.ejpb.2014.08.002_b0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/abbi.1998.0618","article-title":"Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen species","volume":"353","author":"Burkitt","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejpb.2014.08.002_b0210","doi-asserted-by":"crossref","first-page":"26202","DOI":"10.1074\/jbc.270.44.26202","article-title":"Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper","volume":"270","author":"Nobel","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2014.08.002_b0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exer.2006.04.010","article-title":"ALDH3A1: a corneal crystallin with diverse functions","volume":"84","author":"Estey","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2014.08.002_b0220","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.cdd.4401830","article-title":"Reactive oxygen species mediate crosstalk between NF-kappaB and JNK","volume":"13","author":"Nakano","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejpb.2014.08.002_b0225","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ijc.10972","article-title":"Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines","volume":"104","author":"Wang","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejpb.2014.08.002_b0230","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2009.09.002","article-title":"Disulfiram\/copper complex inhibiting NFkappaB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines","volume":"290","author":"Guo","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejpb.2014.08.002_b0235","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/app.31682","article-title":"Rheological evaluation of the isothermal cure characteristics of medical grade silicone elastomers","volume":"116","author":"McConville","year":"2010","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejpb.2014.08.002_b0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.theochem.2008.04.007","article-title":"The molecular structure of disulfiram and its complexation with silica. A quantum chemical study","volume":"861","author":"Sandberg","year":"2008","journal-title":"J. Mol. Struct.: THEOCHEM"},{"key":"10.1016\/j.ejpb.2014.08.002_b0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","article-title":"Improving drug solubility for oral delivery using solid dispersions","volume":"50","author":"Leuner","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.08.002_b0250","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1081\/DDC-120021313","article-title":"Itraconazole formulation studies of the melt-extrusion process with mixture design","volume":"29","author":"Rambali","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2014.08.002_b0255","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0939-6411(00)00077-1","article-title":"Melt extrusion: an alternative method for enhancing the dissolution rate of 17\u03b2-estradiol hemihydrates","volume":"49","author":"H\u00fclsmann","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.08.002_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/js9601896","article-title":"Characteristics and significance of the amorphous state in pharmaceutical systems","volume":"86","author":"Hancock","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2014.08.002_b0265","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13346-011-0031-5","article-title":"Ethylene vinyl acetate intravaginal rings for the simultaneous delivery of the antiretroviral UC781 and contraceptive levonorgestrel","volume":"1","author":"Loxley","year":"2011","journal-title":"Drug Deliv. Transl. Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114002434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114002434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T07:47:59Z","timestamp":1717228079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641114002434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0939641114002434"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.08.002","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}